These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15216467)

  • 1. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
    Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
    J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
    Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
    Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.
    Balaban N; Cirioni O; Giacometti A; Ghiselli R; Braunstein JB; Silvestri C; Mocchegiani F; Saba V; Scalise G
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2226-9. PubMed ID: 17371825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
    Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening.
    Kiran MD; Adikesavan NV; Cirioni O; Giacometti A; Silvestri C; Scalise G; Ghiselli R; Saba V; Orlando F; Shoham M; Balaban N
    Mol Pharmacol; 2008 May; 73(5):1578-86. PubMed ID: 18314496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
    Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.
    Balaban N; Stoodley P; Fux CA; Wilson S; Costerton JW; Dell'Acqua G
    Clin Orthop Relat Res; 2005 Aug; (437):48-54. PubMed ID: 16056025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo.
    Vuong C; Kocianova S; Yao Y; Carmody AB; Otto M
    J Infect Dis; 2004 Oct; 190(8):1498-505. PubMed ID: 15378444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quorum-sensing control in Staphylococci -- a target for antimicrobial drug therapy?
    Otto M
    FEMS Microbiol Lett; 2004 Dec; 241(2):135-41. PubMed ID: 15598524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis.
    Xu L; Li H; Vuong C; Vadyvaloo V; Wang J; Yao Y; Otto M; Gao Q
    Infect Immun; 2006 Jan; 74(1):488-96. PubMed ID: 16369005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAIII Inhibiting Peptide (RIP) and Derivatives as Potential Tools for the Treatment of S. aureus Biofilm Infections.
    Ciulla M; Di Stefano A; Marinelli L; Cacciatore I; Di Biase G
    Curr Top Med Chem; 2018; 18(24):2068-2079. PubMed ID: 30345922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
    Ribeiro PD; Ribeiro OD; Marcolan AM; Medina-Acosta E
    Peptides; 2003 Nov; 24(11):1829-36. PubMed ID: 15019216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.
    McCann MT; Gilmore BF; Gorman SP
    J Pharm Pharmacol; 2008 Dec; 60(12):1551-71. PubMed ID: 19000360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.
    Cirioni O; Ghiselli R; Minardi D; Orlando F; Mocchegiani F; Silvestri C; Muzzonigro G; Saba V; Scalise G; Balaban N; Giacometti A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4518-20. PubMed ID: 17875996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.
    Giacometti A; Cirioni O; Gov Y; Ghiselli R; Del Prete MS; Mocchegiani F; Saba V; Orlando F; Scalise G; Balaban N; Dell'Acqua G
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1979-83. PubMed ID: 12760879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.